SYMFI LO FDA approval date
The FDA approved SYMFI LO on 5 Feb 2018.
- FDA approval date
- 5 Feb 2018
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2018-02-05Day | SYMFI LO | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA208255", "applicant_as_listed_by_fda": "MYLAN", "brand_names": ["SYMFI LO"], "active_ingredients": ["EFAVIRENZ", "LAMIVUDINE", "TENOFOVIR DISOPROXIL FUMARATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20180205", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |